Sangamo Therapeutics Inc (NASDAQ:SGMO) shares, rose in value on Thursday, July 10, with the stock price down by -4.96% to the previous day’s close as strong demand from buyers drove the stock to $0.5.
Actively observing the price movement in the last trading, the stock closed the session at $0.53, falling within a range of $0.4926 and $0.5299. The value of beta (5-year monthly) was 1.21. Referring to stock’s 52-week performance, its high was $3.18, and the low was $0.34. On the whole, SGMO has fluctuated by -1.96% over the past month.
With the market capitalization of Sangamo Therapeutics Inc currently standing at about $122.70 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-12.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 57.68M, with a low estimate of 400k and a high estimate of 100M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 31.68M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that SGMO’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium-term indicators have put the stock in the category of 100% Sell while long-term indicators on average have been pointing out that it is a 100% Sell.
The stock’s technical analysis shows that the price of SGMO currently trading nearly -2.53% and -7.39% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 45.43, while the 7-day volatility ratio is showing 6.88% which for the 30-day chart, stands at 8.76%. Furthermore, Sangamo Therapeutics Inc (SGMO)’s beta value is 1.19.
A comparison of Sangamo Therapeutics Inc (SGMO) with its peers suggests the former has fared considerably weaker in the market. SGMO showed an intraday change of -4.96% in last session, and over the past year, it shrunk by -50.98%%.
Data on historical trading for Sangamo Therapeutics Inc (NASDAQ:SGMO) indicates that the trading volumes over the past 10 days have averaged 4.02 and over the past 3 months, they’ve averaged 5.03 million. According to company’s latest data on outstanding shares, there are 245.40 million shares outstanding.
Nearly 3.16% of Sangamo Therapeutics Inc’s shares belong to company insiders and institutional investors own 21.56% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 25.67 million shares as on 2025-06-13, resulting in a short ratio of 5.16. According to the data, the short interest in Sangamo Therapeutics Inc (SGMO) stood at 1057.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 31.91 million. The stock has risen by 57.04% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the SGMO stock heading into the next quarter.
